These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 3015184

  • 21. Combined modality therapy with radiotherapy, chemotherapy, and immunotherapy in limited small-cell carcinoma of the lung: a Phase III cancer and Leukemia Group B Study.
    Maurer LH, Pajak T, Eaton W, Comis R, Chahinian P, Faulkner C, Silberfarb PM, Henderson E, Rege VB, Baldwin PE.
    J Clin Oncol; 1985 Jul; 3(7):969-76. PubMed ID: 2991478
    [Abstract] [Full Text] [Related]

  • 22. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Hatlevoll R, Dahle R, Boye N, Wang M, Vigander T, Vilsvik J, Skovlund E, Hannisdal E, Aamdal S, Norwegian Lung Cancer Study Group.
    J Clin Oncol; 2002 Dec 15; 20(24):4665-72. PubMed ID: 12488411
    [Abstract] [Full Text] [Related]

  • 23. Combination chemotherapy, radiotherapy, and BCG immunotherapy in limited small-cell carcinoma of the lung: a Southwest Oncology Group Study.
    McCracken JD, Chen T, White J, Samson M, Stephens R, Coltman CA, Saiki J, Lane M, Bonnet J, McGavran M.
    Cancer; 1982 Jun 01; 49(11):2252-8. PubMed ID: 6280836
    [Abstract] [Full Text] [Related]

  • 24. Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial.
    Souhami RL, Geddes DM, Spiro SG, Harper PG, Tobias JS, Mantell BS, Fearon F, Bradbury I.
    Br Med J (Clin Res Ed); 1984 Jun 02; 288(6431):1643-6. PubMed ID: 6326932
    [Abstract] [Full Text] [Related]

  • 25. Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer.
    Ihde DC, Deisseroth AB, Lichter AS, Bunn PA, Carney DN, Cohen MH, Veach SR, Makuch RW, Johnston-Early A, Abrams RA.
    J Clin Oncol; 1986 Oct 02; 4(10):1443-54. PubMed ID: 3020181
    [Abstract] [Full Text] [Related]

  • 26. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W, Frommhold H, Pressler K, Mertelsmann R, Kanz L.
    Semin Oncol; 1995 Feb 02; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [Abstract] [Full Text] [Related]

  • 27. Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer.
    Park YJ, Koh EH, Kim J, Roh JK, Chang J, Ahn CM, Sohn HY, Kim SK, Lee WY, Kim K.
    Yonsei Med J; 1989 Feb 02; 30(1):30-7. PubMed ID: 2545051
    [Abstract] [Full Text] [Related]

  • 28. Alternating chemotherapy and thoracic radiotherapy with concurrent cisplatin-etoposide for limited-stage small-cell carcinoma of the lung.
    Murray N, Shah A, Brown E, Kostashuk E, Laukkanen E, Goldie J, Band P, Van den Hoek J, Murphy K, Sparling T.
    Semin Oncol; 1986 Sep 02; 13(3 Suppl 3):24-30. PubMed ID: 3020695
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study.
    Gregor A, Drings P, Burghouts J, Postmus PE, Morgan D, Sahmoud T, Kirkpatrick A, Dalesio O, Giaccone G.
    J Clin Oncol; 1997 Aug 02; 15(8):2840-9. PubMed ID: 9256127
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R, Cetinayak HO, Sen RC, Demiral AN, Akkoçlu A, Osma E, Kargi A, Oztop I, Onen A, Kinay M, Dokuz Eylül Lung Cancer Study Group.
    J BUON; 2006 Aug 02; 11(1):31-7. PubMed ID: 17318949
    [Abstract] [Full Text] [Related]

  • 33. Split-course versus continuous thoracic radiation therapy for limited-stage small-cell lung cancer: final report of a randomized phase III trial.
    Blackstock AW, Bogart JA, Matthews C, Lovato JF, McCoy T, Livengood K, Ho C, White D, Atkins JN, Miller AA.
    Clin Lung Cancer; 2005 Mar 02; 6(5):287-92. PubMed ID: 15845179
    [Abstract] [Full Text] [Related]

  • 34. A randomized clinical trial comparing systemic radiotherapy versus chemotherapy versus local radiotherapy in small cell lung cancer.
    Hüttner J, Wiener N, Quadt C, Dallüge KH, Grunau H, Tanneberger S, Merkle K.
    Eur J Cancer Clin Oncol; 1989 Jun 02; 25(6):933-7. PubMed ID: 2546778
    [Abstract] [Full Text] [Related]

  • 35. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY, Jiang GL, Wang LJ, Qian H, Fu XL, Yang H, Wu KL, Zhao S.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):70-5. PubMed ID: 15629596
    [Abstract] [Full Text] [Related]

  • 36. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE, Crowley JJ, Blasko JC, Livingston RB, Beck TM, Demattia MD, Bukowski RM.
    J Clin Oncol; 1990 Jan 01; 8(1):39-47. PubMed ID: 2153194
    [Abstract] [Full Text] [Related]

  • 37. A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma. "Petites Cellules" Group.
    Lebeau B, Urban T, Bréchot JM, Paillotin D, Vincent J, Leclerc P, Meekel P, L'Her P, Lebas FX, Chastang C.
    Cancer; 1999 Oct 15; 86(8):1480-7. PubMed ID: 10526276
    [Abstract] [Full Text] [Related]

  • 38. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group.
    Work E, Nielsen OS, Bentzen SM, Fode K, Palshof T.
    J Clin Oncol; 1997 Sep 15; 15(9):3030-7. PubMed ID: 9294465
    [Abstract] [Full Text] [Related]

  • 39. Long-term effects of intravenous hyperalimentation administered during intensive chemotherapy for small cell bronchogenic carcinoma.
    Valdivieso M, Frankmann C, Murphy WK, Benjamin RS, Barkley HT, McMurtrey MJ, Jeffries DG, Welch SR, Bodey GP.
    Cancer; 1987 Jan 15; 59(2):362-9. PubMed ID: 3026605
    [Abstract] [Full Text] [Related]

  • 40. Cure rates in small cell and non-small cell carcinoma of the lung utilizing high-dose radiotherapy and chemotherapy.
    Akbiyik N, Alexander LL.
    J Natl Med Assoc; 1986 Mar 15; 78(3):219-23. PubMed ID: 3012100
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.